PMID- 38258516 OWN - NLM STAT- MEDLINE DCOM- 20240124 LR - 20240202 IS - 1555-3892 (Electronic) IS - 0963-6897 (Print) IS - 0963-6897 (Linking) VI - 33 DP - 2024 Jan-Dec TI - Effect of High BMI on Human Bone Marrow-Derived Mesenchymal Stromal Cells. PG - 9636897241226546 LID - 10.1177/09636897241226546 [doi] LID - 09636897241226546 AB - Bone marrow-derived mesenchymal stromal cells (BMSCs) are attractive candidates in tissue engineering and regenerative medicine. Growing evidence has suggested that a high body mass index (BMI) can affect the properties of BMSCs, resulting in a reduced quality of the cells. However, the results are not consistent. Therefore, this study aimed to investigate the influences of high BMI on human BMSCs (hBMSCs). To avoid gender bias, BMSCs from females and males were studied independently. Finally, hBMSCs from 89 females and 152 males were separately divided into the normal BMI group (18.5 kg/m(2) 25 kg/m(2)). The cells were analyzed for the colony-forming potential; proliferation capacity; in vitro adipogenic, osteogenic, and chondrogenic differentiation potentials; and the expression of 32 common surface antigens. The results showed that high BMI did not change the number of colonies at passage 1 in females and males. In contrast, significantly reduced colony numbers at passage 4 (P4) were found in both female and male donors with high BMI. The doubling time of hBMSCs was comparable between the normal and the high BMI groups of females and males. Furthermore, the results of trilineage differentiation did not differ between the different BMI groups of males. In females, the high and the normal BMI groups also showed similar adipogenic and chondrogenic differentiation, while osteogenic differentiation was significantly enhanced in the high-BMI group. Regarding the expression of surface antigens, the expressions of CD200 and SSEA4 on hBMSCs were reduced in the high-BMI group of females and males, respectively. In conclusion, high BMI suppressed the clonogenicity of female and male hBMSCs at P4, improved the in vitro osteogenesis of female hBMSCs, and decreased the expressions of CD200 on hBMSCs in females and SSEA4 in males. FAU - Zong, Qiang AU - Zong Q AD - Department of Trauma Surgery, Hannover Medical School, Hannover, Germany. FAU - Bundkirchen, Katrin AU - Bundkirchen K AD - Department of Trauma Surgery, Hannover Medical School, Hannover, Germany. FAU - Neunaber, Claudia AU - Neunaber C AD - Department of Trauma Surgery, Hannover Medical School, Hannover, Germany. FAU - Noack, Sandra AU - Noack S AUID- ORCID: 0000-0002-5880-7611 AD - Department of Trauma Surgery, Hannover Medical School, Hannover, Germany. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - United States TA - Cell Transplant JT - Cell transplantation JID - 9208854 RN - 0 (Antigens, Surface) SB - IM MH - Humans MH - Female MH - Male MH - Body Mass Index MH - *Bone Marrow MH - Osteogenesis MH - Sexism MH - Antigens, Surface MH - *Mesenchymal Stem Cells PMC - PMC10807335 OTO - NOTNLM OT - bone marrow-derived mesenchymal stromal cells OT - high BMI OT - obesity OT - overweight COIS- Declaration of Conflicting InterestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article. EDAT- 2024/01/23 06:42 MHDA- 2024/01/24 06:42 PMCR- 2024/01/23 CRDT- 2024/01/23 04:23 PHST- 2024/01/24 06:42 [medline] PHST- 2024/01/23 06:42 [pubmed] PHST- 2024/01/23 04:23 [entrez] PHST- 2024/01/23 00:00 [pmc-release] AID - 10.1177_09636897241226546 [pii] AID - 10.1177/09636897241226546 [doi] PST - ppublish SO - Cell Transplant. 2024 Jan-Dec;33:9636897241226546. doi: 10.1177/09636897241226546.